APA

England K. S., Tumber A., Krojer T., Scozzafava G., Ng S. S., Daniel M., Szykowska A., Che K., von Delft F., Burgess-Brown N. A., Kawamura A., Schofield C. J. & Brennan P. E. (2014). Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. : MedChemComm.

Chicago

England Katherine S, Tumber Anthony, Krojer Tobias, Scozzafava Giuseppe, Ng Stanley S, Daniel Michelle, Szykowska Aleksandra, Che KaHing, von Delft Frank, Burgess-Brown Nicola A, Kawamura Akane, Schofield Christopher J and Brennan Paul E. 2014. Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. : MedChemComm.

Harvard

England K. S., Tumber A., Krojer T., Scozzafava G., Ng S. S., Daniel M., Szykowska A., Che K., von Delft F., Burgess-Brown N. A., Kawamura A., Schofield C. J. and Brennan P. E. (2014). Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. : MedChemComm.

MLA

England Katherine S, Tumber Anthony, Krojer Tobias, Scozzafava Giuseppe, Ng Stanley S, Daniel Michelle, Szykowska Aleksandra, Che KaHing, von Delft Frank, Burgess-Brown Nicola A, Kawamura Akane, Schofield Christopher J and Brennan Paul E. Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. : MedChemComm. 2014.